跳至主要内容
临床试验/NL-OMON33928
NL-OMON33928撤回不适用

TripleFive Pilot Study investigating the feasibilty and initial safety of the (L)IMA bed application of ACF-Matrix haemostat in 10 CABG patients - TripleFive Pilot Study

Gelita Medical BV0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients 18 years of age or older;
  • - Patients showing signs and symptoms of coronary ischemia and/or stenosis who are clinically fit to undergo a CABG operation;
  • - The investigator is satisfied patients have no other ailments that could prevent patients from finishing the study.

排除标准

  • - Patients requiring an acute CABG operation;
  • - Patients partcipating in another clinical trial;
  • - Patients with a local or systemic infection requiring intravenous administration of antibiotics;
  • - Patients with an allergy to porcine products

研究者

发起方
Gelita Medical BV

相似试验